David Tapolczay

David Tapolczay

Chief Executive Officer at CONDUIT PHARMACEUTICALS INC.

Net worth: 6 M $ as of 2024-04-29

64 year
Commercial Services
Health Technology
Consumer Services

Profile

David Joszef Tapolczay founded Sigma Entity One Ltd.
in 2003, where he worked as Chairman & Chief Executive Officer, Nuformix Technologies Ltd.
in 2007, where he worked as Non-Executive Chairman from 2007 to 2020, and Nuformix Plc in 2008, where he worked as Non-Executive Chairman from 2008 to 2020.
Dr. Tapolczay also currently works at Conduit Pharmaceuticals, Inc., as Chief Executive Officer & Director from 2023, Medeor Old Ltd., as Director, Medeor LLP, as Director, and Medeor Pharma Ltd., as Director.
Dr. Tapolczay also formerly worked at The Medical Research Council, as Chief Executive Officer, Lifearc, as Chief Executive Officer from 2008 to 2018, Stylacats Ltd., as Chief Executive Officer, Intelligent OMICS Ltd., as Non-Executive Chairman, Bicycle Therapeutics Plc, as Director, Nanoform Cardiovascular Therapeutics Ltd., as Director, Zeneca Agrochemicals, as Manager in 2013, Cambridge Discovery Chemistry, as Vice President-Research & Development, Glaxo Smithkline Plc, as Senior Manager-Chemical Development, GSK Pharmaceutical Trading SA, as VP-Technology Development from 2005 to 2007, Millenium Group Ltd., as Senior Vice President-Pharmaceutical Sciences, Sigma-Aldrich Co. Ltd., as Chief Scientific Officer, and GSK Group Ltd., as Vice President-Technology Development.
Dr. Tapolczay received his undergraduate degree and doctorate degree from Southampton Business School.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-04-30 2,003,324 ( 2.71% ) 6 M $ 2024-04-29

David Tapolczay active positions

CompaniesPositionStart
CONDUIT PHARMACEUTICALS INC. Chief Executive Officer 2023-09-21
Director/Board Member -
Director/Board Member -
Director/Board Member -
All active positions of David Tapolczay

Former positions of David Tapolczay

CompaniesPositionEnd
Founder 2020-02-04
NUFORMIX PLC Founder 2020-02-04
Chief Executive Officer 2018-11-30
Chief Tech/Sci/R&D Officer 2007-03-31
Glaxo Smithkline Plc /Clinical Pharmacology Unit/ Corporate Officer/Principal -
See the detail of David Tapolczay's experience

Training of David Tapolczay

Southampton Business School Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of David Tapolczay's experience

Connections

25

1st degree connections

21

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
BICYCLE THERAPEUTICS PLC

Health Technology

NUFORMIX PLC

Health Technology

Private companies18
Zeneca Agrochemicals

Glaxo Smithkline Plc /Clinical Pharmacology Unit/

Commercial Services

Commercial Services

Commercial Services

Health Technology

GSK Group Ltd.

Commercial Services

Commercial Services

Health Technology

Stylacats Ltd.

Commercial Services

Health Technology

Commercial Services

Commercial Services

Commercial Services

Nanoform Cardiovascular Therapeutics Ltd.

Conduit Pharmaceuticals, Inc.

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. David Tapolczay